Sales & Marketing News | pharmaphorum

News

Towards a new understanding of cardiovascular risk in diabetes

NICE unlocks use of Amarin's Vazkepa in 425k NHS patients

Health technology assessment (HTA) agency NICE has finalised its guidance on Amarin's Vazkepa, clearing the path for GPs to start prescribing the drug in up to 425,000 NHS patients at high

News

Close up of the columns of the Supreme Court building with an American flag and the US Capitol in the background

Teva asks SCOTUS to overturn "skinny label" verdict on GSK d...

Teva has asked the Supreme Court to look at a judgment in a $235 million patent dispute with GSK that it claims could undermine the ability of generic drugmakers to bring new products to ma

News

EU watchdog formally reprimands Commission over Pfizer texts

The European Commission's failure to reveal text messages between president Ursula von der Leyen and Pfizer chief executive Albert Bourla on COVID-19 vaccine procurement has earned it a for

News

Bayer sells testosterone drug rights to Grünenthal for €500m

Bayer's venerable testosterone replacement product for men with hypogonadism – Nebido – is being sold to Grünenthal as the group continues a revamp of its healthcare business.

News

Packaged Pills in aluminium blisters stacked on each other

New York says Teva lied about role in opioid epidemic

New York's attorney general has accused Teva of lying to evade responsibility for its alleged role in fuelling the opioid epidemic in the state and is asking for a case against the company

News

Innoviva builds in infectious diseases with La Jolla Pharma ...

La Jolla Pharmaceuticals' dreams of building a lucrative business from its stable of drugs used in infectious diseases never really paid off, and the company has now sold itself to royalty

NICE unlocks use of Amarin's Vazkepa in 425k NHS patients

Teva asks SCOTUS to overturn "skinny label" verdict on GSK d...

EU watchdog formally reprimands Commission over Pfizer texts

Bayer sells testosterone drug rights to Grünenthal for €500m

New York says Teva lied about role in opioid epidemic

Innoviva builds in infectious diseases with La Jolla Pharma ...

FDA points to liver injury with Amgen's Tavneos

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks